CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist intervent...
CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist interventions
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundCurrently, oral antineoplastic agents (OAA) represent approximately 40% of all chemotherapy agents. Thus, onco-haematological outpatients have acquired more autonomy and responsibility since OAA require self-administration at home. Hospital pharmacists are the last health professionals in touch with patients and should detect problems rel...
Alternative Titles
Full title
CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist interventions
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2552764601
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552764601
Other Identifiers
ISSN
2047-9956
E-ISSN
2047-9964
DOI
10.1136/ejhpharm-2017-000640.162
